Skip to main content
logo
Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Aug 18, 2026, 11:21 AM EST

Lipella Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.390.540.450.180.260.96
Revenue Growth
-19.39%19.29%144.15%-28.99%-73.03%38.42%
Gross Profit
-3.18-3.08-2.59-2.36-1.2-0.01
Operating Income
-5.41-5.08-4.75-2.59-1.92-0.06
Net Income
-5.33-5.02-4.62-2.6-1.87-0.06
Earnings Per Share
-1.76-4.79-6.16-5.12-4.40-0.23
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
1.862.183.295.121.710.61
Total Debt
0.260.050.140.430.280.33
Net Cash (Debt)
1.592.143.164.691.430.27
Net Cash Growth
24.07%-32.30%-32.71%227.80%420.77%-
Net Cash Per Share
0.522.044.219.243.361.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-4.78-3.95-3.15-1.83-0.99-0.03
Capital Expenditures
---0.01---
Free Cash Flow
-4.78-3.95-3.16-1.83-0.99-0.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
------1.48%
Operating Margin
-1387.94%-947.23%-1055.56%-1406.26%-738.71%-5.91%
Pretax Margin
-1367.37%-935.25%-1027.31%-1410.59%-719.30%-6.41%
Profit Margin
-1367.37%-935.25%-1027.31%-1410.59%-719.30%-6.41%
FCF Margin
-1225.23%-736.59%-703.85%-994.35%-381.45%-2.97%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.006.8813.1797.63--